Safety: NAFDAC warns Nigerian consumers against recalled Nivea Roll-on deodorant

*The National Agency for Food and Drug Administration and Control cautions Nigerians against the affected Nivea Roll-on with the specified batch, reported to contain 2-(4-tert-Butylbenzyl)

propionaldehyde, a chemical prohibited in cosmetic products due to its potential to cause several health hazards to users

Isola Moses | ConsumerConnect

For safety reasons, the National Agency for Food and Drug Administration and Control (NAFDAC) has alerted Nigerian consumers against the use of the recalled Nivea Black & White Invisible Roll-on deodorant, 50ml labelled as providing 48-hour protection in African climates.

NAFDAC caution to consumers came on the heels of a recent warning from the European Union Rapid Alert System for Dangerous non-food products in Brussels.

The Nigerian health regulatory agency, in a notice released on Thursday, October 31, 2024, stated that the batch number of the affected product as 93529610.

It also explained: “The recalled Nivea product is reported to contain 2-(4-tert-Butylbenzyl)

propionaldehyde, a chemical prohibited in cosmetic products due to its potential to cause harm to the reproductive system, impair the health of an unborn child, and cause skin irritation and burns to users.”

NAFDAC further disclosed the affected product is manufactured in Germany, with Bar Code Number 42299882.

The agency, therefore, urged product importers, distributors, retailers, and consumers to exercise caution and vigilance within the supply chain to prevent the importation, distribution, sale, and use of the affected Nivea Roll-on with the specified batch.

The agency, in the notice, also stated: “Members of the public in possession of the affected batch should cease sale or use and submit stock to the nearest NAFDAC office.

“Healthcare professionals and consumers are encouraged to report any adverse events experienced with the use of regulated products to the nearest NAFDAC office, via pharmacovigilance@nafdac.gov.ng, E-reporting platforms available at www.nafdac.gov.ng, or through the Med-safety application available for download on Android and iOS.”